Biotoxtech Co., Ltd.

KOSDAQ:A086040 Stock Report

Market Cap: ₩34.4b

Biotoxtech Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jong-Koo Kang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership14.6%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates

Analysis Article • Sep 01

Improved Revenues Required Before Biotoxtech Co., Ltd. (KOSDAQ:086040) Shares Find Their Feet

You may think that with a price-to-sales (or "P/S") ratio of 1.1x Biotoxtech Co., Ltd. ( KOSDAQ:086040 ) is definitely...
Analysis Article • Oct 21

Improved Revenues Required Before Biotoxtech Co., Ltd. (KOSDAQ:086040) Shares Find Their Feet

Biotoxtech Co., Ltd.'s ( KOSDAQ:086040 ) price-to-sales (or "P/S") ratio of 2.2x might make it look like a buy right...
Analysis Article • May 06

Is Biotoxtech (KOSDAQ:086040) A Risky Investment?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Mar 28

Estimating The Fair Value Of Biotoxtech Co., Ltd. (KOSDAQ:086040)

Today we will run through one way of estimating the intrinsic value of Biotoxtech Co., Ltd. ( KOSDAQ:086040 ) by...
Analysis Article • Feb 20

Did Biotoxtech's (KOSDAQ:086040) Share Price Deserve to Gain 91%?

Some Biotoxtech Co., Ltd. ( KOSDAQ:086040 ) shareholders are probably rather concerned to see the share price fall 32...
Analysis Article • Jan 24

Are Robust Financials Driving The Recent Rally In Biotoxtech Co., Ltd.'s (KOSDAQ:086040) Stock?

Most readers would already be aware that Biotoxtech's (KOSDAQ:086040) stock increased significantly by 15% over the...
Analysis Article • Dec 27

We're Not So Sure You Should Rely on Biotoxtech's (KOSDAQ:086040) Statutory Earnings

As a general rule, we think profitable companies are less risky than companies that lose money. Having said that...
Analysis Article • Nov 30

Is Biotoxtech (KOSDAQ:086040) Using Too Much Debt?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

CEO

Jong-Koo Kang (71 yo)

no data
Tenure

Mr. Jong-Koo Kang, Ph.D. has been the Chief Executive Officer of Biotoxtech Co., Ltd since 2000. Mr. Kang served as the President of Korean Association for Laboratory Animal Science. He was Director-in-Chi...

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/06 11:19
End of Day Share Price 2026/07/06 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Biotoxtech Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Young Ok KimDAOL Investment & Securities Co., Ltd.
Seung-Ho LeeiM Securities